| 1 |
34713454 | Current and future treatment approaches for Barth syndrome. | 2022 Jan |
1 |
| 2 |
35563117 | Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate. | 2022 Apr 25 |
1 |
| 3 |
33031833 | Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial. | 2021 Feb |
2 |
| 4 |
33397369 | Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy. | 2021 Jan 4 |
1 |
| 5 |
33498265 | Lipoprotein Lipase Regulates Microglial Lipid Droplet Accumulation. | 2021 Jan 20 |
1 |
| 6 |
34335707 | Targeting the EZH2-PPAR Axis Is a Potential Therapeutic Pathway for Pancreatic Cancer. | 2021 |
1 |
| 7 |
31713023 | Clinical Management of Primary Biliary Cholangitis-Strategies and Evolving Trends. | 2020 Oct |
1 |
| 8 |
32629063 | Enhancing mitochondrial function in vivo rescues MDS-like anemia induced by pRb deficiency. | 2020 Aug |
1 |
| 9 |
30315479 | Bezafibrate Upregulates Mitochondrial Biogenesis and Influence Neural Differentiation of Human-Induced Pluripotent Stem Cells. | 2019 Jun |
3 |
| 10 |
30515714 | The Role of Oxidative Stress and Bioenergetic Dysfunction in Sulfite Oxidase Deficiency: Insights from Animal Models. | 2019 Feb |
1 |
| 11 |
31163124 | Effects of PPARs/20-HETE on the renal impairment under diabetic conditions. | 2019 Sep 1 |
1 |
| 12 |
29928160 | Update on New Drugs and Those in Development for the Treatment of Primary Biliary Cholangitis. | 2018 Mar |
1 |
| 13 |
30143538 | PPAR-Induced Fatty Acid Oxidation in T Cells Increases the Number of Tumor-Reactive CD8+ T Cells and Facilitates Anti-PD-1 Therapy. | 2018 Nov |
1 |
| 14 |
28097454 | In vitro cytogenetic toxicity of bezafibrate in human peripheral blood lymphocytes. | 2017 Aug |
4 |
| 15 |
26467040 | CYP2C8 Is a Novel Target of Peroxisome Proliferator-Activated Receptor α in Human Liver. | 2016 Jan |
4 |
| 16 |
25134759 | Bezafibrate, a peroxisome proliferator-activated receptor α agonist, decreases circulating CD14(+)CD16(+) monocytes in patients with type 2 diabetes. | 2015 Feb |
1 |
| 17 |
25539886 | Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients: a pilot study. | 2015 Aug |
1 |
| 18 |
26333891 | Ketogenic response to cotreatment with bezafibrate and medium chain triacylglycerols in healthy humans. | 2015 Oct |
2 |
| 19 |
23897856 | Hepatitis C virus induced up-regulation of microRNA-27: a novel mechanism for hepatic steatosis. | 2014 Jan |
1 |
| 20 |
24302581 | PPARα activation can help prevent and treat non-small cell lung cancer. | 2014 Jan 15 |
1 |
| 21 |
24606795 | Mitochondrial biogenesis: pharmacological approaches. | 2014 |
2 |
| 22 |
24950685 | Effects of the environmental contaminants DEHP and TCDD on estradiol synthesis and aryl hydrocarbon receptor and peroxisome proliferator-activated receptor signalling in the human granulosa cell line KGN. | 2014 Sep |
1 |
| 23 |
24511666 | Effectiveness of fenofibrate in comparison to bezafibrate for patients with asymptomatic primary biliary cirrhosis. | 2013 Oct |
1 |
| 24 |
22447153 | Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation. | 2012 Nov |
1 |
| 25 |
22550474 | Conditional Expression of Human PPARδ and a Dominant Negative Variant of hPPARδ In Vivo. | 2012 |
2 |
| 26 |
19683050 | Bezafibrate induces myotoxicity in human rhabdomyosarcoma cells via peroxisome proliferator-activated receptor alpha signaling. | 2010 Feb |
5 |
| 27 |
20404010 | Bezafibrate mildly stimulates ketogenesis and fatty acid metabolism in hypertriglyceridemic subjects. | 2010 Jul |
2 |
| 28 |
21215149 | [Oxidized low density lipoprotein and peroxisome proliferator-activated receptor α induced endogenous fibroblast growth factor 21 upregulation is protective against apoptosis in cardiac endothelial cells]. | 2010 Dec |
1 |
| 29 |
19124612 | Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism. | 2009 Apr |
2 |
| 30 |
19429239 | 15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits fibrogenic response in human hepatoma cells. | 2009 May 22 |
1 |
| 31 |
19667161 | Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells. | 2009 Sep |
1 |
| 32 |
18211970 | Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components. | 2008 Apr |
1 |
| 33 |
18230960 | Optimal management of combined dyslipidemia: what have we behind statins monotherapy? | 2008 |
1 |
| 34 |
17010686 | PPAR agonists modulate human osteoclast formation and activity in vitro. | 2007 Jan |
1 |
| 35 |
15800711 | Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors. | 2005 |
1 |
| 36 |
15936983 | The gene encoding the human ileal bile acid-binding protein (I-BABP) is regulated by peroxisome proliferator-activated receptors. | 2005 Jun 15 |
1 |
| 37 |
15953354 | Regulated expression of endothelial lipase by porcine brain capillary endothelial cells constituting the blood-brain barrier. | 2005 Jul |
1 |
| 38 |
16168052 | Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons. | 2005 Sep 16 |
1 |
| 39 |
16226225 | Fibrates inhibit aldose reductase activity in the forward and reverse reactions. | 2005 Nov 25 |
2 |
| 40 |
14523052 | PPARalpha controls the intracellular coenzyme A concentration via regulation of PANK1alpha gene expression. | 2004 Jan |
2 |
| 41 |
14982965 | A novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-c-5-[4-[5-methyl-2-(4-methylphenyl)-4-oxazolyl]butyl]-1,3-dioxane-r-2-carboxylic acid (NS-220), potently decreases plasma triglyceride and glucose levels and modifies lipoprotein profiles in KK-Ay mice. | 2004 Jun |
1 |
| 42 |
15258199 | Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARalpha-mediated redistribution of ABCB4. | 2004 Oct |
1 |
| 43 |
15521013 | Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites. | 2004 Nov |
1 |
| 44 |
12595494 | PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. | 2003 Mar |
1 |
| 45 |
12759900 | Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages. | 2003 May |
1 |
| 46 |
14615970 | Bezafibrate induces a mitochondrial derangement in human cell lines: a PPAR-independent mechanism for a peroxisome proliferator. | 2003 Nov |
1 |
| 47 |
12000972 | Peroxisome proliferator-activated receptor ligands as antiatherogenic agents: panacea or another Pandora's box? | 2002 Jan |
1 |
| 48 |
11422732 | Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease. | 2001 Jul |
1 |
| 49 |
10753637 | Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. | 2000 Apr 13 |
1 |